Archive

Uncertain population estimates may distort childhood vaccination rates. Health officials are reviewing the data and its implications.

South Africa’s maternal mortality is falling too slowly to meet its 2030 target. Specialists urge earlier antenatal care and better support.

Preventable maternal deaths stem from public health sector inequity and governance failures, not a lack of resources, an analysis argues.

Portugal’s FHC is entering South Africa’s sterile injectables market, planning to build a local plant to challenge established players.

Aspen has abandoned local lenacapavir production, citing no guaranteed demand, and is backing Merck’s alimatravir pill instead.

Discovery Group results for 2026 show profit up 17% to R17.75bn, driven by Discovery Health, the Bank’s turnaround and global Vitality growth.

Mandatory medical scheme membership for taxpayers could cut cover costs by up to 30%, HFA research finds, alongside a risk equalisation fund.

The 2025 Mediscor Medicines Review shows medicine spend up 4.7%, with generics, chronic care and speciality drugs shaping affordability.

Aspen Pharmacare earnings rose 22% as demand for Eli Lilly’s weight-loss drug Mounjaro surged, with the group also eyeing generic semaglutide.

The government will bring traditional health practitioners into the NHI as regulation and benefit-sharing take shape.

Lenacapavir HIV prevention could accelerate South Africa’s epidemic control, but severe supply constraints are limiting the rollout.